Arbutus Biopharma Corp
ABUS- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001447028
No open-market purchases or sales by Arbutus Biopharma Corp insiders were filed in the last 90 days; 176 institutions reported holding it in 13F filings for Q2 2026, worth $674.9M in total; no superinvestor holds it.
Q3 2022 vs. Q2 2022
How the institutions holding Arbutus Biopharma Corp changed between Q2 2022 and Q3 2022.
All holders in Q3 2022All holders in Q2 2022
| Measure | Q2 2022 | Of which not filed for Q3 2022 | Q3 2022 | Change |
|---|---|---|---|---|
| Holders | 113 | 1 | 127 | +15 |
| Shares | 44.3M | 100 | 46.6M | +2.29M (+5.2%) |
| Value | $120.0M | $0 | $89.1M | −$30.9M (−25.8%) |
1 institution that held it in Q2 2022 haven't filed for Q3 2022 yet. Not filing isn't selling, so the changes leave them out.
New holders (20)
Institutions that held Arbutus Biopharma Corp at the end of Q3 2022 but not at the end of Q2 2022.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Oasis Management Co Ltd. | 1,026,672 | $1.96M | 0.34% |
| Marshall Wace, LLP | 392,932 | $751.0K | 0.00% |
| Jacobs Levy Equity Management, Inc | 183,867 | $351.0K | 0.00% |
| Connor, Clark & Lunn Investment Management Ltd. | 90,497 | $173.0K | 0.00% |
| Man Group plc | 87,246 | $167.0K | 0.00% |
| PEAK6 Investments LLC | 62,400 | $119.0K | 0.00% |
| Renaissance Technologies LLC | 45,660 | $87.0K | 0.00% |
| Occudo Quantitative Strategies LP | 42,548 | $81.0K | 0.01% |
| Public Employees Retirement System of Ohio | 39,000 | $74.0K | 0.00% |
| State of Wyoming | 32,832 | $63.0K | 0.03% |
| Schonfeld Strategic Advisors LLC | 31,900 | $61.0K | 0.00% |
| Verus Capital Partners, LLC | 27,700 | $53.0K | 0.01% |
| Two Sigma Investments, LP | 24,442 | $47.0K | 0.00% |
| Arete Wealth Advisors, LLC | 15,000 | $29.0K | 0.00% |
| Sawtooth Solutions, LLC | 14,343 | $27.0K | 0.00% |
| Mariner, LLC | 12,997 | $25.0K | 0.00% |
| Balyasny Asset Management LLC | 12,249 | $23.0K | 0.00% |
| Quadrant Capital Group LLC | 5,401 | $10.0K | 0.00% |
| China Universal Asset Management Co., Ltd. | 1,404 | $3.00K | 0.00% |
| Signaturefd, LLC | 1,108 | $2.00K | 0.00% |
Sold out (5)
Institutions that held Arbutus Biopharma Corp at the end of Q2 2022 and filed for Q3 2022 without it.
| Institution | Shares, Q2 2022 | Value, Q2 2022 |
|---|---|---|
| Brookfield Asset Management Inc. | 1,915,000 | $5.19M |
| Two Sigma Advisers, LP | 64,400 | $175.0K |
| Virtu Financial LLC | 52,722 | $143.0K |
| Sigma Planning Corp | 11,000 | $30.0K |
| Sterling Investment Advisors, Ltd. | 4,000 | $11.0K |
Not filed for Q3 2022 yet (1)
Institutions that held Arbutus Biopharma Corp at the end of Q2 2022 and haven't filed a 13F for Q3 2022. Not filing isn't selling, so they aren't counted as sold out.
| Institution | Shares, Q2 2022 | Value, Q2 2022 |
|---|---|---|
| Lake Point Wealth Management | 100 | $0 |